Online ratings were high for orthopedic surgeons in single metropolitan area
DALLAS — Among 11,535 online reviews of orthopedic surgeons in the Cleveland metropolitan area evaluated in April 2019, the surgeons’ overall average rating was 83.66 using a scale of 0 to 100, in which higher scores represented more positive ratings.
According to Atul F. Kamath, MD, who presented the results of an analysis of reviews of orthopedic surgeons at seven physician-rating websites at the American Association of Hip and Knee Surgeons Annual Meeting, “The average rating of orthopedic surgeons in a single metropolitan area was overwhelmingly positive. The majority of orthopedic surgeons receive 20 or fewer total reviews. Higher ratings for the orthopedic surgeons correlated with staff friendliness, helpfulness, timeliness and punctuality.”
Kamath and his colleagues examined the overall scores and number of reviews for the approximately 680 orthopedic surgeons in the Cleveland metropolitan area. From this, they created subcomponent scores with which the reviews were each rated based on a scale of 0 to 100 that Kamal said was developed based on previously published data.
In addition, the researchers used regression models to identify predictive factors that may inform clinicians how to provide better patient care.
When patients posted more negative reviews, “more perceived knowledge and higher scoring written reviews were associated with resolution of their written complaints as they were expressed,” Kamal said.
During the study discussion period, he said orthopedic surgeons should actively control their data with the move to an online health care marketplace.
“You need to leverage the good reviews you have, and then have you and your staff address bad reviews,” Kamal said. – by Susan M. Rapp
Yu J, et al. Paper 21. Presented at: American Hip and Knee Surgeons Annual Meeting; Nov. 7-10, 2019; Dallas.
Disclosure: Kamath reports he is an AAHKS board or committee member; is a paid presenter or speaker for and receives research support from DePuy Synthes; receives IP royalties from Innomed; has stock or stock options with Johnson & Johnson and Procter & Gamble; and is a paid consultant and a paid presenter or speaker for, receives research support from and has stock or stock options with Zimmer Biomet.